Despite more than a decade of state-level legalization, most adult-use cannabis markets in the United States are failing to meet their core objectives, according to a comprehensive policy analysis released by the Niskanen Center. Illicit markets continue to capture substantial shares of sales in multiple jurisdictions, legal businesses face financial fragility, and public health protections remain inconsistent across states. In California, the illegal market may still claim a larger share of sales than licensed retailers, while the state has seen more licenses become inactive than active, with roughly 15 percent of cannabis operations over $240 million in default on their tax obligations as of 2023. The report identifies legalization not as a single policy event but as a bundle of design choices where regulatory fragmentation, high taxes, licensing delays, and weak enforcement against unlicensed operators have produced what the authors call "a different problem" in which legal markets exist on paper but illicit ones dominate in practice.
The data breakdown reveals systemic barriers to legal market function. About 57 percent of California cities and counties, representing 52 percent of the state's population, don't allow any cannabis retail business. States issued nearly 2,500 violations in 2024, primarily for operating without a license, improper record keeping, and inventory failures. Testing requirements can represent 10 percent of wholesale prices in California, with roughly 25 percent of batches requiring retesting due to inconsistent lab results. In Colorado, a 2025 lawsuit alleged that operators used "ghost facilities" to launder illicit product through licensed premises while diverting legal cannabis to out-of-state markets, costing the state over $100 million in excise tax revenue. Washington state data showed retail prices fell sharply between 2014 and 2016, with higher-THC products commanding higher nominal prices but receiving larger discounts that lowered the effective price per unit of THC. National youth prevalence data from Monitoring the Future showed that past-year cannabis use in 2023 stood at 29 percent in 12th grade, 18 percent in 10th grade, and 8 percent in 8th grade, all down from 2020 peaks.
The report finds that five core problems face adult-use markets: regulatory fragmentation and market fragility, illicit market persistence, business compliance barriers, pricing and tax design failures, and inconsistent public health protections. A sixth force runs through all five: cannabis governance structures in most states "have not been designed to insulate technical and enforcement decisions from commercial influence," with licensing bodies and rulemaking processes "systematically accessible to well-resourced industry actors" while public health constituencies lack equivalent standing. The authors argue that "enforcement against unlicensed operators is largely counterproductive until the legal market can absorb consumer demand," noting that premature crackdowns push consumers toward clandestine channels. They describe California's failure mode not as overly restrictive licensing but as "near-total neglect of enforcement against unlicensed suppliers," giving noncompliant operators a structural cost advantage.
The analysis traces these failures to specific design flaws and argues that successful legalization requires alignment between market structure and public health goals. High prices, unavailability, and inconvenience drive consumers away from legal sources, the report states, while higher product quality, lab testing, shorter distances, and competitive pricing draw them back. Mandatory vertical integration has pushed smaller medical operators out of business and increases barriers to market entry, though it can dampen price volatility. License caps ease administrative burdens but concentrate opportunities among better-capitalized participants. The authors warn that "treating different regulatory regimes as equivalent by coding them as simple on/off indicators produces inconsistent findings precisely because the underlying policy details vary so fundamentally." Testing fraud has undermined consumer trust, with some labs willing to falsify results or inflate THC percentages, creating what the report calls "dry labs" that pressure honest operators. Recent state efforts to decertify repeat offenders and establish reference laboratories show modest improvement, but the authors emphasize that "the credibility of the legal market rests on the ability of consumers and regulators to trust what is on the label."
Looking ahead, the report recommends a three-tier market structure separating producers, distributors, and retailers, with distributors serving as primary compliance chokepoints. It proposes a transitional tax path keeping early burdens moderate while granting regulators authority to adjust rates as markets mature, with potency-based taxation as the long-run target. Connecticut currently charges $0.00625 per milligram THC on flower, the only state applying a true continuous per-milligram rate across all product categories. The authors call for minimum unit pricing linked to THC content to prevent cheap high-potency products from undermining public health goals, and recommend administrative enforcement tools such as license suspensions and civil fines rather than arrest-focused strategies once legal markets stabilize. They propose uniform, portable budtender licenses covering pharmacology, dosing guidance, and recognition of cannabis use disorder symptoms, noting that budtenders remain "essentially a sales role rather than a health-facing, risk-screening, guidance-providing professional." The bottom line: legalization's success depends not on whether states open legal markets but on whether they build regulatory capacity, enforce rules equitably, and design tax and pricing structures that let compliant businesses compete.